IL147043A0 - Quinolinecarboxylic acid derivative or salts thereof - Google Patents

Quinolinecarboxylic acid derivative or salts thereof

Info

Publication number
IL147043A0
IL147043A0 IL14704300A IL14704300A IL147043A0 IL 147043 A0 IL147043 A0 IL 147043A0 IL 14704300 A IL14704300 A IL 14704300A IL 14704300 A IL14704300 A IL 14704300A IL 147043 A0 IL147043 A0 IL 147043A0
Authority
IL
Israel
Prior art keywords
salts
acid derivative
quinolinecarboxylic acid
extremely high
ethylaminoazetidin
Prior art date
Application number
IL14704300A
Other languages
English (en)
Original Assignee
Wakunaga Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharma Co Ltd filed Critical Wakunaga Pharma Co Ltd
Publication of IL147043A0 publication Critical patent/IL147043A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14704300A 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof IL147043A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18749299 1999-07-01
PCT/JP2000/004096 WO2001002390A1 (fr) 1999-07-01 2000-06-22 Derive d'acide quinolinecarboxylique et ses sels

Publications (1)

Publication Number Publication Date
IL147043A0 true IL147043A0 (en) 2002-08-14

Family

ID=16207019

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14704300A IL147043A0 (en) 1999-07-01 2000-06-22 Quinolinecarboxylic acid derivative or salts thereof
IL147043A IL147043A (en) 1999-07-01 2001-12-12 Acid 1 - (6 - amino - 3,5 - difluoropyridine - 2 - ile) - 8 - bromo - 7 - (3 - ethylaminoazethidine - 1 - ile) - 6 - fluoro - 4 - oxo - 4, 1 - dehydroquinoline Carboxylic acid or salt thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147043A IL147043A (en) 1999-07-01 2001-12-12 Acid 1 - (6 - amino - 3,5 - difluoropyridine - 2 - ile) - 8 - bromo - 7 - (3 - ethylaminoazethidine - 1 - ile) - 6 - fluoro - 4 - oxo - 4, 1 - dehydroquinoline Carboxylic acid or salt thereof

Country Status (25)

Country Link
US (1) US6858625B1 (ru)
EP (1) EP1193266B1 (ru)
JP (1) JP3477465B2 (ru)
KR (1) KR100628414B1 (ru)
CN (1) CN1157389C (ru)
AT (1) ATE248162T1 (ru)
AU (1) AU766014B2 (ru)
BR (1) BR0012192A (ru)
CA (1) CA2376760C (ru)
CZ (1) CZ302033B6 (ru)
DE (1) DE60004846T2 (ru)
DK (1) DK1193266T3 (ru)
ES (1) ES2206257T3 (ru)
HK (1) HK1047103B (ru)
HU (1) HUP0201549A3 (ru)
IL (2) IL147043A0 (ru)
MX (1) MXPA02000103A (ru)
NO (1) NO321803B1 (ru)
NZ (1) NZ516201A (ru)
PT (1) PT1193266E (ru)
RU (1) RU2236408C2 (ru)
SK (1) SK285814B6 (ru)
TW (1) TW576832B (ru)
WO (1) WO2001002390A1 (ru)
ZA (1) ZA200110357B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586420B1 (en) 1999-09-02 2003-07-01 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or its salt
US7172535B2 (en) * 2004-10-28 2007-02-06 Volmar John F Upper back exercise machine and method of use
ZA200704862B (en) 2004-11-17 2008-12-31 Wakunaga Pharma Co Ltd Novel pyridonecarboxylic acid derivatives or salts thereof
ES2966093T3 (es) * 2008-09-24 2024-04-18 Melinta Subsidiary Corp Formulación farmacéutica que contiene un derivado de quinolona

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO177302C (no) * 1989-03-16 1995-08-23 Esteve Labor Dr Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
BR9407283A (pt) 1993-08-13 1996-10-01 Dong Wha Pharm Co Ltd Derivados do ácido carboxílico quinolônico e processo de preparação
BR9612862B8 (pt) * 1995-09-22 2014-08-05 Wakunaga Pharma Co Ltd Derivado de ácido piridono carboxílico e agentes antibacteriais.
WO1997040036A1 (fr) * 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
ATE247089T1 (de) 1996-11-28 2003-08-15 Wakunaga Pharma Co Ltd Pyridoncarbonsäurederivate oder ihre salze und diese als aktive bestandteile enthaltende medikamente
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
JPH11292873A (ja) * 1998-04-07 1999-10-26 Dainippon Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法およびその中間体

Also Published As

Publication number Publication date
IL147043A (en) 2007-07-04
KR20020020733A (ko) 2002-03-15
NO20016378L (no) 2002-02-28
CN1358183A (zh) 2002-07-10
ZA200110357B (en) 2002-12-18
NZ516201A (en) 2003-06-30
CZ20014598A3 (cs) 2002-05-15
ATE248162T1 (de) 2003-09-15
SK19162001A3 (sk) 2002-06-04
AU5567900A (en) 2001-01-22
HUP0201549A3 (en) 2003-11-28
DK1193266T3 (da) 2003-11-24
TW576832B (en) 2004-02-21
EP1193266A4 (en) 2002-08-14
EP1193266A1 (en) 2002-04-03
HK1047103A1 (en) 2003-02-07
JP3477465B2 (ja) 2003-12-10
BR0012192A (pt) 2002-06-18
DE60004846T2 (de) 2004-06-03
KR100628414B1 (ko) 2006-09-26
MXPA02000103A (es) 2003-07-21
DE60004846D1 (de) 2003-10-02
AU766014B2 (en) 2003-10-09
NO321803B1 (no) 2006-07-03
CN1157389C (zh) 2004-07-14
HUP0201549A2 (en) 2002-08-28
ES2206257T3 (es) 2004-05-16
PT1193266E (pt) 2003-12-31
NO20016378D0 (no) 2001-12-27
WO2001002390A1 (fr) 2001-01-11
RU2236408C2 (ru) 2004-09-20
EP1193266B1 (en) 2003-08-27
CZ302033B6 (cs) 2010-09-08
CA2376760A1 (en) 2001-01-11
HK1047103B (zh) 2005-04-08
SK285814B6 (sk) 2007-08-02
CA2376760C (en) 2008-11-25
US6858625B1 (en) 2005-02-22

Similar Documents

Publication Publication Date Title
DK0609606T3 (ru)
DK0657448T3 (da) •nbeholderfremgangsmåde til fremstilling af quinoloncarboxylsyrederivater
EE200200207A (et) Kinoliiniderivaatide kasutamine vähivastase ravimi valmistamiseks, ühendite saamine ning neid sisaldavad farmatseutilised kompositsioonid
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
KR950011747B1 (en) Quinoline carboxylic acid perivatives
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CY1112057T1 (el) Θεραπευτικος παραγων για διαταραχη επαρκειας τροφης στο στομαχι
IL147043A0 (en) Quinolinecarboxylic acid derivative or salts thereof
AU4723197A (en) Tricyclic amine derivatives
UA91549C2 (ru) Производные хинолина как антибактериальные агенты
HUP0401562A2 (hu) Kinolinszármazékok és alkalmazásuk tumorellenes szerekként és ezeket tartalmazó gyógyászati készítmények
JP3424038B2 (ja) 合成抗菌剤水性組成物
CY1110244T1 (el) Χαμηλης υγροσκοπικοτητας αριπιπραζολη ως φαρμακευτικη ουσια και μεθοδοι για την παρασκευη της
EP1219618A4 (en) QUINOLINECARBOXYLIC ACID DERIVATIVE OR ITS SALT
ES8506009A1 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
RU2002102491A (ru) Производные хинолинкарбоновой кислоты или их соли
RU2007122499A (ru) Новые производные пиридонкарбоновой кислоты или их соли
MXPA04000952A (es) Sales de derivados de acido 1,2,3-4-tetrahidro-isoquinolin-2-carboxilico.
GB0125658D0 (en) Medicaments
MXPA05009055A (es) Metodo para tratar cancer con derivados de acido quinolona carboxilico.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed